Contact

All Stories

  1. Taking Into Account Insulin Resistance With Associated Hyperinsulinemia to Counteract the Development of Acute and Chronic Cardiovascular Diseases

    Article • Chronic Diseases and Translational Medicine, April 2026, Wiley

    Professor Serafino Fazio

  2. Indomethacin, a drug with known antiviral activity against SARS-CoVs neglected during the COVID-19 pandemic

    Article • Exploration of Medicine, March 2026, Open Exploration Publishing

    Professor Serafino Fazio

  3. Cardiovascular Diseases: From Pathophysiology to Novel Therapeutic Approaches

    Article • Biomedicines, February 2026, MDPI AG

    Professor Serafino Fazio

  4. Association of insulin and GH/IGF-1 derangements and heart failure: a narrative review

    Article • Exploration of Cardiology, February 2026, Open Exploration Publishing

    Professor Serafino Fazio

  5. Insulin Resistance/Hyperinsulinemia Should Be Considered in the Prevention and Treatment of Essential Hypertension

    Article • Biomedicines, December 2025, MDPI AG

    Professor Serafino Fazio

  6. Feature Reviews in Cardiovascular Diseases

    Article • Biomedicines, October 2025, MDPI AG

    Professor Serafino Fazio

  7. Aging of the vascular system: proposal of preventive intervention with known natural substances

    Article • Exploration of Cardiology, August 2025, Open Exploration Publishing

    Professor Serafino Fazio

  8. COVID-19 vaccinations in adults and evaluation of cardiovascular events: critical methodological issues

    Article • European Heart Journal, February 2025, Oxford University Press (OUP)

    Professor Serafino Fazio

  9. Insulin Resistance with Associated Hyperinsulinemia as a Cause of the Development and Worsening of Heart Failure

    Article • Biomedicines, December 2024, MDPI AG

    Professor Serafino Fazio

  10. Autoantibodies Targeting G-Protein-Coupled Receptors and RAS-Related Molecules in Post-Acute COVID Vaccination Syndrome: A Retrospective Case Series Study

    Article • Biomedicines, December 2024, MDPI AG

    Professor Serafino Fazio

  11. Chronically Increased Levels of Circulating Insulin Secondary to Insulin Resistance: A Silent Killer

    Article • Biomedicines, October 2024, MDPI AG

    Professor Serafino Fazio

  12. Insulin Resistance, a Risk Factor for Alzheimer’s Disease: Pathological Mechanisms and a New Proposal for a Preventive Therapeutic Approach

    Article • Biomedicines, August 2024, MDPI AG

    Professor Serafino Fazio

  13. Insulin Resistance/Hyperinsulinemia as an Independent Risk Factor That Has Been Overlooked for Too Long

    Article • Biomedicines, June 2024, MDPI AG

    Professor Serafino Fazio

  14. Insulin Resistance/Hyperinsulinemia, Neglected Risk Factor for the Development and Worsening of Heart Failure with Preserved Ejection Fraction

    Article • Biomedicines, April 2024, MDPI AG

    Professor Serafino Fazio

  15. Insulin resistance/hyperinsulinemia: an important cardiovascular risk factor that has long been underestimated

    Article • Frontiers in Cardiovascular Medicine, March 2024, Frontiers

    Professor Serafino Fazio

  16. A case of adverse reaction to booster dose of COVID-19 vaccination: could D-dimer elevation suggest increased clotting risk?

    Article • January 2024, Authorea, Inc.

    Professor Serafino Fazio

  17. The Negative Impact of Insulin Resistance/Hyperinsulinemia on Chronic Heart Failure and the Potential Benefits of Its Screening and Treatment

    Article • Biomedicines, October 2023, MDPI AG

    Professor Serafino Fazio

  18. Editorial: Methods in general cardiovascular medicine

    Article • Frontiers in Cardiovascular Medicine, August 2023, Frontiers

    Professor Serafino Fazio

  19. A Descriptive Review of the Action Mechanisms of Berberine, Quercetin and Silymarin on Insulin Resistance/Hyperinsulinemia and Cardiovascular Prevention

    Article • Molecules, June 2023, MDPI AG

    Professor Serafino Fazio

  20. Early Multi-Target Treatment of Mild-to-Moderate COVID-19, Particularly in Terms of Non-Steroidal Anti-Inflammatory Drugs and Indomethacin

    Article • BioMed, March 2023, MDPI AG

    Professor Serafino Fazio

  21. COVID-19 Medical and Pharmacological Management in the European Countries Compared to Italy: An Overview

    Article • International Journal of Environmental Research and Public Health, April 2022, MDPI AG

    Geir Bjorklund, Professor Serafino Fazio

  22. A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Management of Mild-to-Moderate Symptomatic COVID-19

    Article • Medical Science Monitor, February 2022, International Scientific Literature

    Professor Serafino Fazio

  23. Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis of Early COVID-19 and Treated at Home Within 3 Days or After 3 Days of Symptom Onset with Prescribed and Non-Prescribed Treatments Between Novembe...

    Article • Medical Science Monitor, December 2021, International Scientific Literature

    Professor Serafino Fazio

  24. Home pharmacological therapy in early COVID‐19 to prevent hospitalization and reduce mortality: Time for a suitable proposal

    Article • Basic & Clinical Pharmacology & Toxicology, December 2021, Wiley

    Professor Serafino Fazio

  25. Sustained High D-Dimer in Outpatients Who Have Recovered from Mild to Moderate Coronavirus Disease 2019 (COVID-19)

    Article • Seminars in Thrombosis and Hemostasis, May 2021, Thieme Publishing Group

    Professor Serafino Fazio

  26. COVID-19: Off-label therapies based on mechanism of action while waiting for evidence-based medicine recommendations

    Article • World Journal of Meta-Analysis, June 2020, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Professor Serafino Fazio

  27. A nutraceutical combination improves insulin sensitivity in patients with metabolic syndrome: A randomized, double-blind, placebo-controlled trial

    Article • Vascular Pharmacology, December 2015, Elsevier

    Professor Serafino Fazio

  28. Efficacy of sildenafil in HIV-related pulmonary arterial hypertension

    Article • Journal of Cardiovascular Medicine, January 2015, Wolters Kluwer Health

    Professor Serafino Fazio

  29. Response to letter by Wang Q et al. regarding article “Serum soluble ST2 and interleukin-33 levels in patients with pulmonary arterial hypertension”

    Article • International Journal of Cardiology, October 2013, Elsevier

    Professor Serafino Fazio

  30. Serum soluble ST2 and interleukin-33 levels in patients with pulmonary arterial hypertension

    Article • International Journal of Cardiology, September 2013, Elsevier

    Professor Serafino Fazio

  31. Response to pulmonary vasodilator treatment in a former smoker with combined interstitial lung disease complicated by pulmonary hypertension: Case report and review of the literature

    Article • Heart & Lung, September 2012, Elsevier

    Professor Serafino Fazio

  32. Effects of a nutraceutical combination on left ventricular remodeling and vasoreactivity in subjects with the metabolic syndrome

    Article • Nutrition Metabolism and Cardiovascular Diseases, May 2012, Elsevier

    Professor Serafino Fazio

  33. Reply:

    Article • Pacing and Clinical Electrophysiology, January 2012, Wiley

    Professor Serafino Fazio

  34. A nutraceutical combination improves insulin sensitivity in patients with metabolic syndrome

    Article • World Journal of Cardiology, January 2012, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Professor Serafino Fazio

  35. Insulin resistance: Is it time for primary prevention?

    Article • World Journal of Cardiology, January 2012, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Professor Serafino Fazio

  36. The Importance of Tricuspid Regurgitation and Right Ventricular Overload in ICD/CRT Recipients: Beside the Left, beyond the Left

    Article • Pacing and Clinical Electrophysiology, August 2011, Wiley

    Professor Serafino Fazio

  37. Endocrine Alterations Are the Main Determinants of Cardiac Remodelling in Restrictive Anorexia Nervosa

    Article • ISRN Endocrinology, July 2011, Hindawi Publishing Corporation

    Professor Serafino Fazio

  38. Cardiac involvement in active uncomplicated acromegaly

    Article • International Journal of Angiology, April 2011, Thieme Publishing Group

    Professor Serafino Fazio

  39. A NUTRACEUTICAL COMBINATION IMPROVES INSULIN SENSITIVITY IN PATIENTS WITH METABOLIC SYNDROME: RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

    Article • Journal of the American College of Cardiology, April 2011, Elsevier

    Professor Serafino Fazio

  40. Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo-controlled study

    Article • Nutrition Metabolism and Cardiovascular Diseases, November 2010, Elsevier

    Professor Serafino Fazio

  41. Letter by Fazio and Carlomagno Regarding Article, “Heart Rate Predicts Outcomes in an Implantable Cardioverter-Defibrillator Population”

    Article • Circulation, June 2010, Wolters Kluwer Health

    Professor Serafino Fazio

  42. Thyroid Hormones and Cardiovascular System: From Bench to Bedside

    Article • Current Drug Therapy, February 2010, Bentham Science Publishers

    Professor Serafino Fazio

  43. Late Onset of Hypoxemia Due to a Pulmonary Arteriovenous Malformation During Selective Estrogen Receptor Modulator Therapy

    Article • Journal of the American College of Cardiology, February 2010, Elsevier

    Professor Serafino Fazio

  44. Cardiovascular and metabolic effects of Berberine

    Article • World Journal of Cardiology, January 2010, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Professor Serafino Fazio

  45. Efficacy and safety of valsartan plus hydroclorothiazide for high blood pressure

    Article • World Journal of Cardiology, January 2010, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Professor Serafino Fazio

  46. Long term combination treatment for severe idiopathic pulmonary arterial hypertension

    Article • World Journal of Cardiology, January 2010, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Professor Serafino Fazio

  47. Usefulness of NT-proBNP in the assessment of patients with aortic or mitral regurgitation

    Article • Journal of Cardiovascular Medicine, December 2009, Wolters Kluwer Health

    Professor Serafino Fazio

  48. Growth Hormone Deficiency in Patients with Chronic Heart Failure and Beneficial Effects of Its Correction

    Article • The Journal of Clinical Endocrinology & Metabolism, September 2009, Endocrine Society

    Professor Serafino Fazio

  49. The GH/IGF-1 Axis and Heart Failure

    Article • Current Cardiology Reviews, August 2009, Bentham Science Publishers

    Professor Serafino Fazio

  50. Myocarditis and dilated cardiomyopathy: possible connections and treatments

    Article • Journal of Cardiovascular Medicine, July 2008, Wolters Kluwer Health

    Professor Serafino Fazio

  51. Effects of Growth Hormone on Exercise Capacity and Cardiopulmonary Performance in Patients with Chronic Heart Failure

    Article • The Journal of Clinical Endocrinology & Metabolism, November 2007, Endocrine Society

    Professor Serafino Fazio

  52. Prehypertension and Elevated Risk of Cardiovascular Disease: Physiopathologic Mechanisms

    Article • The American Journal of Medicine, April 2007, Elsevier

    Professor Serafino Fazio

  53. Association between post-ischemic forearm blood flow and blood pressure response to maximal exercise in well trained healthy young men

    Article • International Journal of Cardiology, August 2006, Elsevier

    Professor Serafino Fazio

  54. Tadalafil improves quality of life and exercise tolerance in idiopathic pulmonary arterial hypertension

    Article • International Journal of Cardiology, April 2006, Elsevier

    Professor Serafino Fazio

  55. Aerobic exercise performance correlates with post-ischemic flow-mediated dilation of the brachial artery in young healthy men

    Article • European Journal of Applied Physiology and Occupational Physiology, January 2005, Springer Science + Business Media

    Professor Serafino Fazio

  56. Tadalafil in Primary Pulmonary Arterial Hypertension

    Article • Annals of Internal Medicine, November 2004, American College of Physicians

    Professor Serafino Fazio

  57. Long-term efficacy of doxazosin plus atenolol in the management of severe and sustained arterial hypertension and reversibility of the cardiac damage induced by chronic cathecolamine excess. A case report in a young girl with recurrent, functioning par...

    Article • Journal of Endocrinological Investigation, September 2004, Springer Science + Business Media

    Professor Serafino Fazio

  58. Myocardial contractility and total arterial stiffness in patients with overt hyperthyroidism: acute effects of beta1-adrenergic blockade

    Article • European Journal of Endocrinology, June 2004, Oxford University Press (OUP)

    Professor Serafino Fazio

  59. Peak exercise oxygen uptake and left ventricular systolic and diastolic function and arterial mechanics in healthy young men

    Article • European Journal of Applied Physiology and Occupational Physiology, May 2004, Springer Science + Business Media

    Professor Serafino Fazio

  60. Effects of Thyroid Hormone on the Cardiovascular System

    Article • Recent Progress in Hormone Research, January 2004, Endocrine Society

    Professor Serafino Fazio

  61. Hyperthyroidism, Subclinical

    Article • January 2004, Elsevier

    Professor Serafino Fazio

  62. Subclinical Hypothyroidism and Cardiovascular Risk

    Article • Treatments in Endocrinology, January 2004, Springer Science + Business Media

    Professor Serafino Fazio

  63. Subclinical Thyroid Dysfunction and the Heart

    Article • Annals of Internal Medicine, November 2003, American College of Physicians

    Professor Serafino Fazio

  64. Reactive hyperemia and cardiovascular performance in athletes regularly trained

    Article • American Journal of Hypertension, May 2003, Oxford University Press (OUP)

    Professor Serafino Fazio

  65. Prospective Evaluation of Hypertensive Patients with Carotid Kinking and Coiling: An Ultrasonographic 7-Year Study

    Article • Angiology, March 2003, SAGE Publications

    Professor Serafino Fazio

  66. Cardiovascular Safety of Acute Recombinant Human Thyrotropin Administration to Patients Monitored for Differentiated Thyroid Cancer

    Article • The Journal of Clinical Endocrinology & Metabolism, January 2003, Endocrine Society

    Professor Serafino Fazio

  67. The importance of using strict inclusion criteria in subclinical hypothyroid studies

    Article • The American Journal of Medicine, January 2003, Elsevier

    Professor Serafino Fazio

  68. Effects of Subclinical Thyroid Dysfunction on the Heart

    Article • Annals of Internal Medicine, December 2002, American College of Physicians

    Professor Serafino Fazio

  69. Improvement of left ventricular hypertrophy and arrhythmias after lanreotide-induced GH and IGF-I decrease in acromegaly. A prospective multi-center study

    Article • Journal of Endocrinological Investigation, December 2002, Springer Science + Business Media

    Professor Serafino Fazio

  70. Patients with Subclinical Cushing’s Syndrome due to Adrenal Adenoma Have Increased Cardiovascular Risk

    Article • The Journal of Clinical Endocrinology & Metabolism, November 2002, Endocrine Society

    Professor Serafino Fazio

  71. Subclinical Hypothyroidism and Cardiac Function

    Article • Thyroid, June 2002, Mary Ann Liebert Inc

    Professor Serafino Fazio

  72. Supraphysiological Doses of GH Induce Rapid Changes in Cardiac Morphology and Function

    Article • The Journal of Clinical Endocrinology & Metabolism, April 2002, Endocrine Society

    Professor Serafino Fazio

  73. Supraphysiological Doses of GH Induce Rapid Changes in Cardiac Morphology and Function

    Article • The Journal of Clinical Endocrinology & Metabolism, April 2002, Endocrine Society

    Professor Serafino Fazio

  74. Aldosterone Receptor Blockade in the Management of Heart Failure

    Article • Heart Failure Reviews, April 2002, Springer Science + Business Media

    Professor Serafino Fazio

  75. Effects of Thyroid Hormone on Cardiac Function - The Relative Importance of Heart Rate, Loading Conditions, and Myocardial Contractility in the Regulation of Cardiac Performance in Human Hyperthyroidism

    Article • The Journal of Clinical Endocrinology & Metabolism, March 2002, Endocrine Society

    Professor Serafino Fazio

  76. Effects of Thyroid Hormone on Cardiac Function - The Relative Importance of Heart Rate, Loading Conditions, and Myocardial Contractility in the Regulation of Cardiac Performance in Human Hyperthyroidism

    Article • The Journal of Clinical Endocrinology & Metabolism, March 2002, Endocrine Society

    Professor Serafino Fazio

  77. Mortality in elderly patients with subclinical hyperthyroidism

    Article • The Lancet, March 2002, Elsevier

    Professor Serafino Fazio

  78. Mortality in elderly patients with subclinical hyperthyroidism

    Article • The Lancet, March 2002, Elsevier

    Professor Serafino Fazio

  79. Growth hormone corrects vascular dysfunction in patients with chronic heart failure

    Article • Journal of the American College of Cardiology, January 2002, Elsevier

    Professor Serafino Fazio

  80. Impact of Hyperthyroidism and Its Correction on Vascular Reactivity in Humans

    Article • Circulation, December 2001, Wolters Kluwer Health

    Professor Serafino Fazio

  81. Does the Growth Factor Approach Have a Future in the Treatment of Human Heart failure?

    Article • January 2001, Springer Science + Business Media

    Professor Serafino Fazio

  82. Endogenous Subclinical Hyperthyroidism Affects Quality of Life and Cardiac Morphology and Function in Young and Middle-Aged Patients*

    Article • The Journal of Clinical Endocrinology & Metabolism, December 2000, Endocrine Society

    Professor Serafino Fazio

  83. Endogenous Subclinical Hyperthyroidism Affects Quality of Life and Cardiac Morphology and Function in Young and Middle-Aged Patients

    Article • The Journal of Clinical Endocrinology & Metabolism, December 2000, Endocrine Society

    Professor Serafino Fazio

  84. Growth hormone and cardiac function

    Article • April 2000, Cambridge University Press

    Professor Serafino Fazio

  85. The role of the GH-IGF-I axis in the regulation of myocardial growth: from experimental models to human evidence

    Article • European Journal of Endocrinology, March 2000, Oxford University Press (OUP)

    Professor Serafino Fazio

  86. Cardiovascular Effects of Short-Term Growth Hormone Hypersecretion

    Article • The Journal of Clinical Endocrinology & Metabolism, January 2000, Endocrine Society

    Professor Serafino Fazio

  87. Cardiovascular Effects of Short-Term Growth Hormone Hypersecretion

    Article • The Journal of Clinical Endocrinology & Metabolism, January 2000, Endocrine Society

    Professor Serafino Fazio

  88. Heart Failure: Potential Benefit of Growth Hormone Therapy

    Article • January 2000, Springer Science + Business Media

    Professor Serafino Fazio

  89. A Direct Role for the Macrophage Low Density Lipoprotein Receptor in Atherosclerotic Lesion Formation

    Article • Journal of Biological Chemistry, July 1999, Elsevier

    Professor Serafino Fazio

  90. Left Ventricular Diastolic Dysfunction in Patients with Subclinical Hypothyroidism

    Article • The Journal of Clinical Endocrinology & Metabolism, June 1999, Endocrine Society

    Professor Serafino Fazio

  91. Left Ventricular Diastolic Dysfunction in Patients with Subclinical Hypothyroidism

    Article • The Journal of Clinical Endocrinology & Metabolism, June 1999, Endocrine Society

    Professor Serafino Fazio

  92. Growth Hormone and the Heart

    Article • Mineral and Electrolyte Metabolism, January 1999, Karger Publishers

    Professor Serafino Fazio

  93. Growth hormone as a potential future therapy for congestive heart failure

    Article • Coronary Artery Disease, January 1999, Wolters Kluwer Health

    Professor Serafino Fazio

  94. Growth Hormone in Heart Failure

    Article • January 1999, Springer Science + Business Media

    Professor Serafino Fazio

  95. Cardiac Effects of Growth Hormone in Physiology and in Heart Failure

    Article • Endocrine Journal, January 1999, Japan Endocrine Society

    Professor Serafino Fazio

  96. Doxorubicin‐induced cardiomyopathy treated with carvedilol

    Article • Clinical Cardiology, September 1998, Wiley

    Professor Serafino Fazio

  97. Reentrant Atrioventricular Nodal Tachycardia Induced by Levothyroxine

    Article • The Journal of Clinical Endocrinology & Metabolism, August 1998, Endocrine Society

    Professor Serafino Fazio

  98. Sympathetic deactivation by growth hormone treatment in patients with dilated cardiomyopathy

    Article • European Heart Journal, April 1998, European Society of Cardiology

    Professor Serafino Fazio

  99. Increased Arterial Intima-Media Thickness in Childhood-Onset Growth Hormone Deficiency

    Article • The Journal of Clinical Endocrinology & Metabolism, May 1997, Endocrine Society

    Professor Serafino Fazio

  100. Increased Arterial Intima-Media Thickness in Childhood-Onset Growth Hormone Deficiency

    Article • The Journal of Clinical Endocrinology & Metabolism, May 1997, Endocrine Society

    Professor Serafino Fazio

  101. Growth hormone and heart performance: A novel mechanism of cardiac wall stress regulation in humans

    Article • European Heart Journal, February 1997, European Society of Cardiology

    Professor Serafino Fazio

  102. Prevalence of Carotid Kinking and Coiling in a Population at Risk

    Article • Vascular Surgery, January 1997, SAGE Publications

    Professor Serafino Fazio

  103. Impaired cardiac reserve and exercise capacity in patients receiving long-term thyrotropin suppressive therapy with levothyroxine

    Article • The Journal of Clinical Endocrinology & Metabolism, December 1996, Endocrine Society

    Professor Serafino Fazio

  104. Growth Hormone in the Treatment of Dilated Cardiomyopathy

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, August 1996, New England Journal of Medicine (NEJM/MMS)

    Professor Serafino Fazio

  105. Cardiovascular aspects in acromegaly: Effects of treatment

    Article • Metabolism, August 1996, Elsevier

    Professor Serafino Fazio

  106. Improved left ventricular function after growth hormone replacement in patients with hypopituitarism: Assessment with radionuclide angiography

    Article • European Journal of Pediatrics, April 1996, Springer Science + Business Media

    Professor Serafino Fazio

  107. A Preliminary Study of Growth Hormone in the Treatment of Dilated Cardiomyopathy

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, March 1996, New England Journal of Medicine (NEJM/MMS)

    Professor Serafino Fazio

  108. Long-term growth hormone deficiency as a cause of cardiomyopathy and its reversibility with specific replacement therapy.

    Article • The Journal of Clinical Endocrinology & Metabolism, March 1996, Endocrine Society

    Professor Serafino Fazio

  109. Long-term growth hormone deficiency as a cause of cardiomyopathy and its reversibility with specific replacement therapy

    Article • The Journal of Clinical Endocrinology & Metabolism, March 1996, Endocrine Society

    Professor Serafino Fazio

  110. Cardiac performance: Growth hormone enters the race

    Article • Nature Medicine, January 1996, Springer Science + Business Media

    Professor Serafino Fazio

  111. Impairment of lung volumes and respiratory muscle strength in adult patients with growth hormone deficiency

    Article • European Journal of Endocrinology, December 1995, Oxford University Press (OUP)

    Professor Serafino Fazio

  112. Optimal determination of right ventricular filling dynamics in systemic hypertension

    Article • American Heart Journal, November 1995, Elsevier

    Professor Serafino Fazio

  113. Diastolic dysfunction in patients on thyroid-stimulating hormone suppressive therapy with levothyroxine: beneficial effect of beta- blockade

    Article • The Journal of Clinical Endocrinology & Metabolism, July 1995, Endocrine Society

    Professor Serafino Fazio

  114. Pacemaker Malfunction Due to Subcutaneous Emphysema

    Article • Vascular Surgery, March 1995, SAGE Publications

    Professor Serafino Fazio

  115. Growth Hormone and the Heart

    Article • Endocrine Reviews, October 1994, Endocrine Society

    Professor Serafino Fazio

  116. Growth hormone and the heart

    Article • Endocrine Reviews, October 1994, Endocrine Society

    Professor Serafino Fazio

  117. Impaired cardiac performance in GH-deficient adults and its improvement after GH replacement

    Article • AJP Endocrinology and Metabolism, August 1994, American Physiological Society

    Professor Serafino Fazio

  118. Impaired cardiac performance is a distinct feature of uncomplicated acromegaly

    Article • The Journal of Clinical Endocrinology & Metabolism, August 1994, Endocrine Society

    Professor Serafino Fazio

  119. Control of adrenergic overactivity by beta-blockade improves the quality of life in patients receiving long term suppressive therapy with levothyroxine

    Article • The Journal of Clinical Endocrinology & Metabolism, May 1994, Endocrine Society

    Professor Serafino Fazio

  120. Cardiac Effects of Long Term Thyrotropin-Suppressive Therapy with Levothyroxine

    Article • The Endocrinologist, May 1994, Wolters Kluwer Health

    Professor Serafino Fazio

  121. Body composition, bone metabolism, and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low doses

    Article • The Journal of Clinical Endocrinology & Metabolism, December 1993, Endocrine Society

    Professor Serafino Fazio

  122. Cardiac structural and functional abnormalities in adult patients with growth hormone deficiency

    Article • The Journal of Clinical Endocrinology & Metabolism, December 1993, Endocrine Society

    Professor Serafino Fazio

  123. Chronic treatment with the somatostatin analog octreotide improves cardiac abnormalities in acromegaly

    Article • The Journal of Clinical Endocrinology & Metabolism, September 1993, Endocrine Society

    Professor Serafino Fazio

  124. Cardiac effects of long term thyrotropin-suppressive therapy with levothyroxine

    Article • The Journal of Clinical Endocrinology & Metabolism, August 1993, Endocrine Society

    Professor Serafino Fazio

  125. Platelet Aggregability in Patients with a VVI Pacemaker

    Article • Pacing and Clinical Electrophysiology, February 1993, Wiley

    Professor Serafino Fazio

  126. Evidence for biventricular involvement in acromegaly: a Doppler echocardiographic study

    Article • European Heart Journal, January 1993, European Society of Cardiology

    Professor Serafino Fazio

  127. Capillary Blood Flow to the Skin of Forearm in Cirrhosis

    Article • Angiology, December 1992, SAGE Publications

    Professor Serafino Fazio

  128. Influence of atenolol on the relationship between heart rate and qt interval in patients with exercise‐induced myocardial ischemia

    Article • Clinical Cardiology, December 1992, Wiley

    Professor Serafino Fazio

  129. Pacemaker Malfunction Due to Subcutaneous Emphysema — A Case Report

    Article • Angiology, October 1992, SAGE Publications

    Professor Serafino Fazio

  130. Evaluation, by Noninvasive Methods, of the Effects of Acute Loss of Thyroid Hormones on the Heart

    Article • Angiology, April 1992, SAGE Publications

    Professor Serafino Fazio

  131. Follow‐Up of a Respiratory Rate Modulated Pacemaker

    Article • Pacing and Clinical Electrophysiology, January 1992, Wiley

    Professor Serafino Fazio

  132. Fourier Analysis in Patients with Different Pacing Modes

    Article • Pacing and Clinical Electrophysiology, September 1991, Wiley

    Professor Serafino Fazio

  133. Efficacy of Ticlopidine in the Prevention of Thromboembolic Events in Patients with VVI Pacemakers

    Article • Pacing and Clinical Electrophysiology, February 1991, Wiley

    Professor Serafino Fazio

  134. Cardiac function and sympathetic activity in young diabetics

    Article • Pharmacological Research, September 1990, Elsevier

    Professor Serafino Fazio

  135. Cardiac function and sympathetic activity in young diabetics

    Article • Diabetes Research and Clinical Practice, January 1990, Elsevier

    Professor Serafino Fazio

  136. A prospective randomized trial of doxorubicinversus idarubicin in the treatment of advanced breast cancer

    Article • Cancer, December 1989, Wiley

    Professor Serafino Fazio

  137. Atenolol and Amiodarone: A Comparative Study of Their Anti-Ischaemic Effect

    Article • Journal of International Medical Research, March 1988, SAGE Publications

    Professor Serafino Fazio

  138. Bisoprolol in the treatment of angina pectoris: a double blind comparison with verapamil

    Article • European Heart Journal, December 1987, European Society of Cardiology

    Professor Serafino Fazio

  139. Indapamide and atenolol in the treatment of hypertension: double-blind comparative and combination study

    Article • Current Medical Research and Opinion, January 1983, Informa Healthcare

    Professor Serafino Fazio

  140. Obesity and cardiac function.

    Article • Circulation, September 1981, Wolters Kluwer Health

    Professor Serafino Fazio